Cargando…
Turmeric-derived nanovesicles as novel nanobiologics for targeted therapy of ulcerative colitis
Rationale: Ulcerative colitis (UC), a typical kind of inflammatory bowel disease (IBD), is an idiopathic chronic intestinal inflammation. Conventional therapeutic strategies mainly focus on the rebalance of pro-inflammation and anti-inflammation cytokines, whereas targeting damaged intestinal barrie...
Autores principales: | Gao, Caifang, Zhou, Yangyang, Chen, Zhejie, Li, Hongyi, Xiao, Yaqin, Hao, Wei, Zhu, Ying, Vong, Chi Teng, Farag, Mohamed A., Wang, Yitao, Wang, Shengpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330521/ https://www.ncbi.nlm.nih.gov/pubmed/35910802 http://dx.doi.org/10.7150/thno.73650 |
Ejemplares similares
-
A polyphenol-assisted IL-10 mRNA delivery system for ulcerative colitis
por: Chen, Zhejie, et al.
Publicado: (2022) -
Targeted delivery of Chinese herb pair-based berberine/tannin acid self-assemblies for the treatment of ulcerative colitis
por: Chen, Shiyun, et al.
Publicado: (2021) -
Engineering polyphenol-based carriers for nucleic acid delivery
por: Shui, Mingju, et al.
Publicado: (2023) -
Ginseng: A bibliometric analysis of 40-year journey of global clinical trials
por: Chen, Weijie, et al.
Publicado: (2020) -
Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy
por: Liu, Cui, et al.
Publicado: (2022)